Literature DB >> 24696773

Chromosome duplication (14q) and the genotype phenotype correlation.

Ariane Sadr-Nabavi1, Morteza Saeidi2.   

Abstract

The rearrangement of chromosome 14 is a rare cytogenetic finding. Changes in the number or structure of chromosome 14 can have a variety of effects, such as delayed growth and development, and distinctive facial features. The human chromosome 14 plays an important role in imprinting events importunes of a structural rearrangement is specifically when a phenotype is caused by imprinting, whereby the interpretation of genotype-phenotype correlation becomes extremely difficult. In this study, we examined a 3 year-old mentally impaired girl with unusual facial features. G-banding showed terminal duplication of chromosome 14 in the karyotype of the patient. In this particular case, we explained a phenotype genotype correlation in a patient with a dup (14) rearrangement, thus emphasizing the importance of prenatal diagnosis for pregnancies with an abnormal nuchal translucency.

Entities:  

Keywords:  Chromosome 14; Chromosome Duplication; Mental Retardation

Year:  2014        PMID: 24696773      PMCID: PMC3973161     

Source DB:  PubMed          Journal:  Int J Fertil Steril        ISSN: 2008-0778


Introduction

A chromosome anomaly can be (a) Numerical: there is one (or more) chromosome(s) in excess (trisomy) or missing (monosomy) resulting in the karyotype being always unbalanced and (b) Structural: the change is balanced, if there is no loss or gain of genetic material but unbalanced, if there is deletion and/or duplication of chromosome segment(s). In an unbalanced chromosome rearrangement, the chromosomal complement contains an incorrect amount of chromosome material and the clinical effects are usually serious. Duplication is one of the structural changes that results in an unbalanced rearrangement. There are two types of duplication: 1. Direct: segment of chromosome is repeated, once or several times, the duplicated segment keeping the same orientation with respect to the centromere ("tandem duplication") and 2. Inverted: the duplicated segment takes the opposite orientation (1, 2). Chromosomes in the human genome is the chromosome 14, the short arm of this chromosome is characterized by heterochromatin which contain ribosomal RNA genes. The long arm of this chromosome is euchromatin that most of the geneslocatedon , is the protein-codinggenes (3) . About 106 million base pairs (bp) DNA building blocks spans the chromosome 14. This is approximately 3.5 percent of the total DNA in the cells and contain between 800 and 1,300 genes (4). The chromosome 14 is one of the human chromosomes known to have an imprinting affect. In the human chromosome, 14-uniparental disomy (UPD) describes the inheritance of both the homologs of a pair of chromosomes from an individual parent. Though genomic imprinting is correct in UPD, problems arise due to the normal chromosome segregation, therefore causing false imprinting. The phenotypes have been described for maternal UPD 14 respectively (5-10). Paternal UPD 14 is associated with developmental delay. Both maternal UPD 14 and paternal UPD 14 rarely appear in individuals . Here we describe the clinical features associated with a dup (14) observed in a 3 year-old girl. G- banding was used for detailed evaluation of the chromosomal gains and losses.

Case report

In a cousin marriage between a 29 year old female and a 35 year old male, following a 15 hours prolonged labor, a child was born by caesarean section. The infant’s weight, height and head circumference at birth were 2200 g, 46 cm and 31cm respectively. The result in biochemistry was creatine 0.4 mg/l, in hematology HCT 25%, platelet 530000, PT 16.5 sec. PTT 36 sec and INR 1.5. Overtime the mother noticed delay in the growth and development of the child and opted for a different workup. In the new laboratory assessments , the following findings were observed : Zinc: 59 mcg/dl (N: 63.8-110), Sweat test: (weight 529 mg, Cl- 20, Na+ 20), ABG: pH: 7.38, PO2 : 33.5 mmHg, HCO3 -: 19.9 mmol/l, PCO2 : 33.2 mmHg and O2 Sat: 63.1%. Following abnormal ABG and mild cyanosis in the patient, echocardiography was carried out and the results were PDA, ASD20size 7-8mm, L->R shunt, good ejection fraction and no pulmonary hypertension. The patient underwent surgery via Video-Assissted Thoracoscopy (VATS) and Ductus which was closed using double liga clips. Since then her weight loss has continued. She received hormone therapy which was rendered ineffective and finally a genetic consultation was carried out. The patient was admitted to the Imam Khomeini Hospital in Tehran on 03.09.2010 at the age of 34 months. At present, the girl’s weight and height are at 7100 g and 54 cm respectively. She has gained the ability to sit and as of lately can manage a few one-syllable words. She suffers from skin allergy, insomnia and recurrent gastroenteritis and is undergoing physiotherapy and occupational therapy. The patient was diagnosed to be mentally impaired with an unusual facial feature, including a high forehead, epicanthic folds, large and low set ears, a small jaw and chin and also a large tongue. In her lower extremities, overlapping toes was noted. A neurological examination revealed evidence of generalized weakness accompanied with reduced muscle tone, diminished deep tendon reflexes and some diatonic features in the distal parts of the extremities. Due to muscle weakness in the lower limbs, the patient was unable to walk unassisted and also had difficulty in sitting (Fig 1).
Fig 1

Examination revealed evidence of generalized weakness with reduced muscle tone and diminishment. Patient was unable to walk unassisted and also had difficulty sitting.

Examination revealed evidence of generalized weakness with reduced muscle tone and diminishment. Patient was unable to walk unassisted and also had difficulty sitting. Conventional cytogenetic analysis of cultured lymphocytes was performed. Blood samples were obtained through venipuncture and collected into heparinized syringes. For each 2 subject, three lymphocyte cultures were usually set up according to conventional techniques. Cultures were made in Ham’s F10 (Biochrom) medium supplemented with LymphoGrow (100ml; Complete medium 12% newborn calf serum, 7.8 μg/ml Phytohaemagglutinin (PHA, CytoGen, Germany), LymphoGrow II (100ml; Complete medium 14% newborn calf serum, 8.8 μg/ml phytohemagglutinin) (CytoGen, Germany). The cells were grown at 37˚C for 48 to 72 hours. Cultures were treated with colchicine (10 μg/ml) (Life Technologies/Invitrogen) during the last 3hrs of incubation. Cultures were harvested using protocol, including hypotonic treatment of 0.56% KCl (0,065 M) (Merck/ VWR) for 20 minutes at 37˚C and three periods of fixation in methanol: glacial acetic acid (3:1). Flame-dried slides were prepared and stained by Giemsa technique. Cytogenetic analysis revealed a 46, XX, dup (14) karyotype (Fig 2). The rearrangement was present in all the 25 analyzed cells. Although the breakpoint was difficult to assign, the G-banding displayed duplication of chromosome 14 at region 2 and band 4. The resolution of the banding was approximately 350 bands. Karyotype analysis of the parents signifies that a de novo rearrangement has occured in this particular patient. Banding of chromosome 14 [dup (14)].

Discussion

It seems that the chromosomal aberration provides a good explanation for the clinical features of our patient. Cytogenetic analysis revealed a 46, XX, dup (14) karyotype (Fig 2). Transmitted duplications are often slightly less reported than deletions. Glass et al. (11) list parent-to-child transmission of duplications of chromosome 7p, 8p, 9p, 14q and 15q that have been listed in the literature. Since the breakpoint of this duplication was not clear, the exact duplication region of chromosome 14q was not specified. With high resolution G-banding. The resolution of the banding was approximately 350 bands. The general phenotype of the patient was growth and mental retardation, dystrophic features and muscle weakness. This phenotype has been also seen in a patient with chromosome 15 anomalies (12). The human chromosome 15 is known to have an imprinting effect. The phenotypic consequence of genomic imprinting may result from one of the two mechanisms: overexpression of a parent-specific transcript or absence of a parent- specific transcript. Examples of an overexpression of a parent-specific transcript include the imprinted genes involved in Beckwith- Wiedemann syndrome (13) and Russell-Silver syndrome (14).
Fig 2

Banding of chromosome 14 [dup (14)].

Examples of absent parent-specific gene expression include brain specific expression of UBE3A in Angelman syndrome (15) and most likely the gene(s) involved in Prader-Willi syndrome (16). As for chromosome 14 and UPD, either mechanism is possible. However, in our opinion based on the comparison between the phenotypes of UPD 14 cases and chromosome 14 duplication cases, the sense of a parentspecific transcript (functional trisomy) results in the phenotypes being associated with maternal and paternal UPD 14. Furthermore, the genes mapped to chromosome 14q are among similar genes encoding placental growth factor (14q24.3), neuroglobin (14q24.3), creatine kinase (14q32) and ataxin3 (14q21) which play major roles in carnal and mental evolutions. Therefore, the duplication of this region could result in the associated phenotypes (17-20). The present study reports a chromosomal duplication syndrome. Our results suggest that genetic counselling and a follow up karyotyping should be performed when an increased nuchal translucency is observed.
  18 in total

1.  Molecular studies in 37 Silver-Russell syndrome patients: frequency and etiology of uniparental disomy.

Authors:  T Eggermann; H A Wollmann; R Kuner; K Eggermann; H Enders; P Kaiser; M B Ranke
Journal:  Hum Genet       Date:  1997-09       Impact factor: 4.132

2.  The DNA sequence and analysis of human chromosome 14.

Authors:  Roland Heilig; Ralph Eckenberg; Jean-Louis Petit; Núria Fonknechten; Corinne Da Silva; Laurence Cattolico; Michaël Levy; Valérie Barbe; Véronique de Berardinis; Abel Ureta-Vidal; Eric Pelletier; Virginie Vico; Véronique Anthouard; Lee Rowen; Anup Madan; Shizhen Qin; Hui Sun; Hui Du; Kymberlie Pepin; François Artiguenave; Catherine Robert; Corinne Cruaud; Thomas Brüls; Olivier Jaillon; Lucie Friedlander; Gaelle Samson; Philippe Brottier; Susan Cure; Béatrice Ségurens; Franck Anière; Sylvie Samain; Hervé Crespeau; Nissa Abbasi; Nathalie Aiach; Didier Boscus; Rachel Dickhoff; Monica Dors; Ivan Dubois; Cynthia Friedman; Michel Gouyvenoux; Rose James; Anuradha Madan; Barbara Mairey-Estrada; Sophie Mangenot; Nathalie Martins; Manuela Ménard; Sophie Oztas; Amber Ratcliffe; Tristan Shaffer; Barbara Trask; Benoit Vacherie; Chadia Bellemere; Caroline Belser; Marielle Besnard-Gonnet; Delphine Bartol-Mavel; Magali Boutard; Stéphanie Briez-Silla; Stephane Combette; Virginie Dufossé-Laurent; Carolyne Ferron; Christophe Lechaplais; Claudine Louesse; Delphine Muselet; Ghislaine Magdelenat; Emilie Pateau; Emmanuelle Petit; Peggy Sirvain-Trukniewicz; Arnaud Trybou; Nathalie Vega-Czarny; Elodie Bataille; Elodie Bluet; Isabelle Bordelais; Maria Dubois; Corinne Dumont; Thomas Guérin; Sébastien Haffray; Rachid Hammadi; Jacqueline Muanga; Virginie Pellouin; Dominique Robert; Edith Wunderle; Gilbert Gauguet; Alice Roy; Laurent Sainte-Marthe; Jean Verdier; Claude Verdier-Discala; LaDeana Hillier; Lucinda Fulton; John McPherson; Fumihiko Matsuda; Richard Wilson; Claude Scarpelli; Gábor Gyapay; Patrick Wincker; William Saurin; Francis Quétier; Robert Waterston; Leroy Hood; Jean Weissenbach
Journal:  Nature       Date:  2003-01-01       Impact factor: 49.962

Review 3.  Epigenetics and human disease.

Authors:  Yong-Hui Jiang; Jan Bressler; Arthur L Beaudet
Journal:  Annu Rev Genomics Hum Genet       Date:  2004       Impact factor: 8.929

4.  Trisomy 2q11.2-->q21.1 resulting from an unbalanced insertion in two generations.

Authors:  I A Glass; P Stormer; P T Oei; E Hacking; P D Cotter
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

5.  Uniparental disomy (UPD) other than 15: phenotypes and bibliography updated.

Authors:  Dieter Kotzot; Gerd Utermann
Journal:  Am J Med Genet A       Date:  2005-07-30       Impact factor: 2.802

Review 6.  New onset epilepsy in Prader-Willi syndrome: semiology and literature review.

Authors:  Leslie A Benson; Kiran P Maski; Sanjeev V Kothare; Blaise F Bourgeois
Journal:  Pediatr Neurol       Date:  2010-10       Impact factor: 3.372

7.  Control of cardiovascular variability during undisturbed wake-sleep behavior in hypocretin-deficient mice.

Authors:  Alessandro Silvani; Stefano Bastianini; Chiara Berteotti; Viviana Lo Martire; Giovanna Zoccoli
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-02-22       Impact factor: 3.619

8.  Clinical heterogeneity associated with deletions in the long arm of chromosome 15: report of 3 new cases and their possible genetic significance.

Authors:  L C Kaplan; R Wharton; E Elias; F Mandell; T Donlon; S A Latt
Journal:  Am J Med Genet       Date:  1987-09

Review 9.  Review and meta-analysis of systematic searches for uniparental disomy (UPD) other than UPD 15.

Authors:  Dieter Kotzot
Journal:  Am J Med Genet       Date:  2002-09-01

10.  A new phenotype of brain iron accumulation with dystonia, optic atrophy, and peripheral neuropathy.

Authors:  Rita Horvath; Elke Holinski-Feder; Vivienne C M Neeve; Angela Pyle; Helen Griffin; Deephthi Ashok; Charlotte Foley; Gavin Hudson; Bernd Rautenstrauss; Gudrun Nürnberg; Peter Nürnberg; Jörg Kortler; Birgit Neitzel; Ingelore Bässmann; Thahira Rahman; Bernard Keavney; John Loughlin; Sophie Hambleton; Benedikt Schoser; Hanns Lochmüller; Mauro Santibanez-Koref; Patrick F Chinnery
Journal:  Mov Disord       Date:  2012-04-16       Impact factor: 10.338

View more
  1 in total

1.  Recombinant chromosome with partial 14 q trisomy due to maternal pericentric inversion.

Authors:  Hande Küçük Kurtulgan; Leyla Özer; Malik Ejder Yıldırım; Evrim Ünsal; Süleyman Aktuna; Volkan Baltacı; Nejmiye Akkuş; İlhan Sezgin
Journal:  Mol Cytogenet       Date:  2015-11-21       Impact factor: 2.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.